CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −7,978 | $119.54 | $954K | 583,225 |
| 2025-10-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −2,022 | $118.82 | $240K | 581,203 |
| 2025-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +515 | 43,917 | ||
| 2025-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −241 | $120.94 | $29K | 43,676 |
| 2025-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −515 | 19,816 | ||
| 2025-10-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −3,000 | $118.08 | $354K | 110,193 |
| 2025-10-15 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −2,500 | $118.08 | $295K | 157,055 |
| 2025-09-29 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −8,039 | $111.47 | $896K | 593,164 |
| 2025-09-29 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −1,961 | $112.42 | $220K | 591,203 |
| 2025-09-22 | Burkhart Erin SVP, Controllership | Grant or award · Restricted Stock Unit | +8,890 | 8,890 | ||
| 2025-09-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −3,000 | $113.57 | $341K | 113,193 |
| 2025-09-15 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −2,500 | $113.57 | $284K | 159,555 |
| 2025-09-10 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +1,315 | 44,036 | ||
| 2025-09-10 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −634 | $115.25 | $73K | 43,402 |
| 2025-09-10 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −1,315 | 20,331 | ||
| 2025-09-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +3,844 | 118,012 | ||
| 2025-09-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −1,819 | $115.25 | $210K | 116,193 |
| 2025-09-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −3,844 | 31,516 | ||
| 2025-09-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +10,427 | 606,152 | ||
| 2025-09-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −4,949 | $115.25 | $570K | 601,203 |
Page 13 of 30 · 599 trades